Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > All time low!

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Nov 13, 2023 9:10pm

190 Views

Post# 35733367

RE:RE:RE:RE:RE:All time low!

Of course the covid lockdown slowed down the trial study by one or two years and then the dosage miscalculation. Expect the unexpected. In the meantime let's dream the next two unexpected events are BTD and a 10% JV for $300 million. TLT management is pretty good at keeping stuff close to the vest so who knows what's in the works and when it will happen. GLTA.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing